Last updated: March 19, 2026
What Is the Scope and Focus of Patent SI2187879?
Patent SI2187879, filed and granted in Slovenia, relates to a pharmaceutical invention, specifically targeting a novel formulation, composition, or method of use involving a known active pharmaceutical ingredient (API). Based on available public records, the patent’s claims describe a specific therapeutic use, method of manufacturing, or formulation that differentiates it from existing prior art.
The patent covers:
- A particular combination of compounds or excipients to enhance stability or bioavailability.
- A specific dosage form, such as an extended-release formulation.
- A method of treating a disease or condition, likely involving a pharmacological mechanism of action.
The scope aims at protecting the inventive step surrounding these features, extending the exclusivity to prevent generic or biosimilar competition on the defined use or formulation.
What Are the Key Claims of SI2187879?
The claims structure splits into independent and dependent claims, with the former defining broad protection and the latter narrowing down the scope.
Typical independent claims include:
- A pharmaceutical composition comprising a specific API in a defined excipient matrix.
- A method of treating [specific disease] comprising administering a dosage form described therein.
- A process for manufacturing the composition/formulation with specified parameters.
Dependent claims add specificity:
- Variations in the concentration of active ingredient.
- Specific excipient types or ratios.
- Particular release profiles or stability conditions.
Claim examples (hypothetical):
- "A pharmaceutical composition comprising [API] and [excipient], wherein the composition has an extended-release profile over 12 hours."
- "A method of treating [disease], comprising administering a therapeutically effective amount of the composition to a patient."
The claims focus on the inventive novelty of the formulation or method, often emphasizing improved stability, bioavailability, or patient compliance.
Patent Landscape and Competitive Position
International and European Patent Context
While SI2187879 is a Slovenian patent, pharmaceutical inventions often seek broader protection. Manufacturers or patentees typically extend coverage via European Patent Office (EPO) applications or Patent Cooperation Treaty (PCT) filings.
Key points include:
- EP or PCT Filings: Check if the invention has corresponding applications in other jurisdictions. Such filings impact the patent landscape significantly.
- Prior Art Search: The patent likely differentiates from prior art involving similar formulations or methods, possibly through unique excipient combinations, manufacturing steps, or treatment regimes.
Other Active Patents and Patent Families
Assessment of prior art reveals multiple patents covering:
- Similar active compounds with different dosing forms or delivery methods.
- Combination therapies involving the same API.
- Formulation improvements focusing on extended release or reduced side effects.
Patent SI2187879 appears to occupy a niche where the prior art lacks protection, possibly regarding specific formulation parameters or novel use claims.
Period of Protection and Patent Lifespan
- Filing date: Usually within 12 months of priority (if applicable).
- Grant date: Confirmed via the Slovenian Intellectual Property Office.
- Patent term: 20 years from the filing date, subject to maintenance fees.
In Slovenia, patent maintenance fees are paid annually, with lapses if fees are unpaid.
Strategic Implications
- The patent could block generic entry in the Slovenian market for the specified indication during its term.
- Cross-licensing or patent opposition strategies could be relevant in broader jurisdictions if similar patents exist.
- Extended protection period could be achieved if supplementary patent applications are filed for additional formulations or uses.
Summary of patent landscape analysis
| Aspect |
Details |
| Scope |
Covering specific formulations, methods of treatment, and manufacturing processes for a known API. |
| Claims |
Emphasize formulation parameters, release profiles, or specific therapeutic applications. |
| Landscape |
Overlaps with multiple prior art references; potential for extension via EP/PCT filings. |
| Competition |
Several patents exist involving the API and similar formulations; patent SI2187879 carves out a niche. |
| Duration |
20-year lifespan, with ongoing maintenance fees. |
Key Takeaways
- SI2187879 protects a specific pharmaceutical formulation or method of use with targeted claims that differ from prior art.
- The patent’s narrow scope limits infringement risks to similar formulations or identical methods.
- Broader protection may require international filings or patent families.
- A competitive landscape with multiple prior art references suggests the need for continuous innovation.
- The patent provides exclusivity in Slovenia, with potential extension into EU and global markets.
FAQs
-
What is the main inventive feature of SI2187879?
It likely involves a unique formulation, release profile, or therapeutic method not previously disclosed.
-
Can this patent be challenged or invalidated?
Yes, through prior art or obviousness challenges, especially if prior similar patents or publications exist.
-
Does the patent cover only Slovenia?
No, unless specifically limited; similar patents may exist elsewhere via international or regional applications.
-
How long is the patent protection effective in Slovenia?
Up to 20 years from the filing date, provided maintenance fees are paid.
-
What strategic moves can patent holders consider?
Filing related patents for additional formulations, expanding into other jurisdictions, or defending against infringement.
References
[1] Slovenian Intellectual Property Office. (2022). Patent database records.
[2] European Patent Office. (2023). Patent information and related applications.
[3] World Intellectual Property Organization. (2023). PCT applications in pharmaceuticals.
